<bill session="109" type="s" number="109" updated="2020-02-10T17:00:09Z">
  <state datetime="2005-01-24">REFERRED</state>
  <status>
    <introduced datetime="2005-01-24"/>
  </status>
  <introduced datetime="2005-01-24"/>
  <titles>
    <title type="short" as="introduced">Pharmaceutical Market Access Act of 2005</title>
    <title type="display">Pharmaceutical Market Access Act of 2005</title>
    <title type="official" as="introduced">A bill entitled the "Pharmaceutical Market Access Act of 2005".</title>
  </titles>
  <sponsor bioguide_id="V000127"/>
  <cosponsors>
    <cosponsor bioguide_id="D000595" joined="2005-01-24"/>
    <cosponsor bioguide_id="L000550" joined="2005-03-14" withdrawn="2005-04-04"/>
    <cosponsor bioguide_id="S001163" joined="2005-01-24"/>
    <cosponsor bioguide_id="T000250" joined="2005-01-24"/>
  </cosponsors>
  <actions>
    <action datetime="2005-01-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2005-01-24" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S278-282" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="109" type="h" number="328" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative fees"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Business records"/>
    <term name="Civil actions and liability"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Consumer protection"/>
    <term name="Damages"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Electronic government information"/>
    <term name="Evidence (Law)"/>
    <term name="Federal Trade Commission"/>
    <term name="Federal-state relations"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Identification devices"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Independent regulatory commissions"/>
    <term name="Injunctions"/>
    <term name="Intellectual property"/>
    <term name="Internet"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Limitation of actions"/>
    <term name="Packaging"/>
    <term name="Parties to actions"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Product counterfeiting"/>
    <term name="Product safety"/>
    <term name="Punitive damages"/>
    <term name="Restrictive trade practices"/>
    <term name="Science, Technology, Communications"/>
    <term name="Telephone"/>
    <term name="Web sites"/>
    <term name="Wholesale trade"/>
  </subjects>
  <amendments/>
  <summary date="2005-03-24T13:41:36Z" status="Introduced in Senate">Pharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to promulgate regulations permitting pharmacists, pharmacies, wholesalers, and individuals to import qualifying drugs from certain countries into the United States.

Sets forth registration requirements for exporters.

Requires the Secretary to: (1) educate consumers with regard to the availability of qualifying drugs for import for personal use; (2) inspect the facilities and records of importers and registered exporters to ensure compliance with this Act; and (3) establish a registration fee program to collect an annual fee from registered exporters.

Deems a prescription drug to be misbranded unless the packaging of such drug complies with the requirements for counterfeit-resistant technologies.

Prohibits: (1) failing to register in accordance with this Act; and (2) importing or offering to import a prescription drug in violation of a suspension order.

Declares that selling or importing a patented drug in the United States that was first sold abroad by or under authority of the owner or licensee of the patent is not patent infringement.

Prohibits drug manufacturers from discriminating against a person that engages in the importation of a prescription drug, including by charging higher prices or denying supplies of the drug.

Allows the Secretary to suspend or terminate the registration of an exporter for failing to maintain substantial compliance with all registration conditions.</summary>
</bill>
